VR Logo

Exact Sciences Corporation (EXAS) download report


Healthcare | Diagnostics Services

Exact Sciences Corporation (EXAS) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.

IPO Date: 01-Feb-2001

Chairman of The Board & CEO: Mr. Kevin T. Conroy

Exec. VP, CFO & COO: Mr. Jeffrey T. Elliott CFA

Listing: NASDAQ: EXAS

Country: United States

Headquarters: Madison, WI

Website: https://www.exactsciences.com

Key Facts

Market cap: $7,236.62 Mln

Revenue (TTM): $1,851.58 Mln

Earnings (TTM): $-745.40 Mln

Cash: $816.98 Mln

Total Debt: $2,382.02 Mln

Insider's Holding: 0.89%

Liquidity: Low

52 Week range: $35.34 - 125.00

Shares outstanding: 175,944,992

10 Years Aggregate:

  • CFO: $-650.26 Mln
  • EBITDA: $-2,138.59 Mln
  • Net Profit: $-2,341.74 Mln

Stock Performance

Time Period Exact Sciences (EXAS) S&P BSE Sensex* S&P Midcap 400*
YTD-47.15-8.62-19.22
1 month-23.59-4.54-8.89
3 months-41.18-10.19-14.77
1 Year-66.911.43-14.84
3 Years-29.6310.145.68
5 Years3.0611.265.62
10 Years14.3911.829.32
As on 01-Jul-2022 *As on 04-Jul-2022
Year Exact Sciences (EXAS) S&P Midcap 400 S&P BSE Sensex
2021-41.2623.2121.99
202043.2611.8115.75
201946.5624.0514.38
201819.98-12.435.87
2017293.2614.4527.91
201644.7518.731.95
2015-66.36-3.71-5.03